Impact of exacerbations on lung function, resource utilization, and productivity: results from an observational, prospective study in adults with uncontrolled asthma

被引:5
|
作者
Wisnivesky, Juan [1 ,2 ]
Federmann, Emily [1 ]
Eckert, Laurent [3 ]
West, Erin [4 ]
Amand, Caroline [3 ]
Kamar, Driss [5 ]
Teper, Ariel [6 ]
Khan, Asif H. [3 ]
机构
[1] Icahn Sch Med Mt Sinai, Div Gen Internal Med, Box 1087,One Gustave L Levy Pl, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Pulm & Crit Care Med, New York, NY 10029 USA
[3] Sanofi, Chilly Mazarin, France
[4] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland
[5] Ividata Life Sci, Levallois Perret, France
[6] Sanofi, Bridgewater Township, NJ USA
关键词
Forced expiratory volume; symptom exacerbation; airway disease; asthma exacerbations; healthcare resource utilization; DECLINE;
D O I
10.1080/02770903.2022.2130800
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Exacerbations have a major impact on the well-being of patients with uncontrolled asthma. This study evaluated lung function, healthcare resource utilization (HCRU), and productivity loss following asthma exacerbations.Methods: This single-center, observational, prospective cohort study recruited US patients presenting clinically with an acute asthma exacerbation; a reference group without exacerbations was included for comparison. Lung function (forced expiratory volume in 1 second [FEV1]) was collected at baseline, daily during Month 1, and monthly for Months 2-5, and reported as FEV1 percent predicted (FEV(1)pp). HCRU (outpatient visits to a healthcare practitioner, emergency room [ER] visits, and hospitalizations for asthma), oral corticosteroid (OCS) use, and asthma-related work/school absence were collected monthly for 6 months.Results: Overall, 150 patients were recruited (exacerbation: n=102; reference: n=48; mean [SD] age: 42.7 [15.2] and 49.6 [12.4] years; female: 73% and 71%). In both groups, similar trends were observed in FEV1, with significant improvement from baseline to Week 1 (p<0.05), followed by a continuous decline. FEV(1)p was 7.7% lower at baseline and 8.6% lower at Month 5 in the exacerbation group versus the reference group. The exacerbation group had significantly higher rates of OCS prescription during follow-up versus reference group (p=0.04). Over half (52.9%) of patients in the exacerbation group had a recurrent exacerbation during follow-up, increased HCRU (outpatient visits, ER visits, and hospitalizations), and impaired productivity.Conclusion: Although patients with exacerbations had rapid recovery of lung function, this was not maintained and declined faster than in patients without exacerbations. Additionally, patients experienced increased HCRU after exacerbations.
引用
收藏
页码:1072 / 1079
页数:8
相关论文
共 50 条
  • [21] Impact of mild COVID-19 on balance function in young adults, a prospective observational study
    Guzik, Agnieszka
    Wolan-Nieroda, Andzelina
    Kochman, Maciej
    Perenc, Lidia
    Druzbicki, Mariusz
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [22] Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study
    Hanania, N. A.
    Bateman, E. D.
    Castro, M.
    Pavord, I. D.
    Papi, A.
    FitzGerald, J. M.
    Maspero, J. F.
    Katelaris, C.
    Singh, D.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Staudinger, H. W.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [23] Asthma and lung function 20 years after wheezing in infancy - Results from a prospective follow-up study
    Piippo-Savolainen, E
    Remes, S
    Kannisto, S
    Korhonen, K
    Korppi, M
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2004, 158 (11): : 1070 - 1076
  • [24] No association between vitamin D and atopy, asthma, lung function or atopic dermatitis: a prospective study in adults
    Thuesen, B. H.
    Heede, N. G.
    Tang, L.
    Skaaby, T.
    Thyssen, J. P.
    Friedrich, N.
    Linneberg, A.
    ALLERGY, 2015, 70 (11) : 1501 - 1504
  • [25] Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
    Menzies-Gow, Andrew
    Corren, Jonathan
    Bourdin, Arnaud
    Chupp, Geoffrey
    Israel, Elliot
    Griffiths, Janet
    Hellqvist, Asa
    Bowen, Karin
    Kaur, Primal
    Almqvist, Gun
    Ponnarambil, Sandhia
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB249 - AB249
  • [26] Health resource utilization associated with skeletal-related events in patients with advanced breast cancer: results from a prospective, multinational observational study
    Lueftner, Diana
    Lorusso, Vito
    Duran, Ignacio
    Hechmati, Guy
    Garzon-Rodriguez, Cristina
    Ashcroft, John
    Bahl, Amit
    Ghelani, Prayashi
    Wei, Rachel
    Thomas, Emma
    Hoefeler, Herbert
    SPRINGERPLUS, 2014, 3 : 1 - 10
  • [27] Dupilumab Reduces Severe Exacerbations and Improves Lung Function Regardless of Baseline Bronchodilator Reversibility in Patients with Uncontrolled Moderate-to-Severe Asthma Enrolled in the LIBERTY ASTHMA QUEST Study
    Pavord, I.
    Castro, M.
    Rabe, K. F.
    Hanania, N. A.
    Papi, A.
    FitzGerald, J. M.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Staudinger, H. W.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [28] DUPILUMAB REDUCES EXACERBATIONS AND IMPROVES LUNG FUNCTION IN UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA PATIENTS REGARDLESS OF PRIOR EXACERBATION HISTORY IN THE PHASE 3 LIBERTY ASTHMA QUEST STUDY
    Pavord, I.
    Ford, L. B.
    Corren, J.
    Kuna, P.
    Dong, Q.
    Staudinger, H.
    Maroni, J.
    Rowe, P.
    Rout, R.
    Amin, N.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    THORAX, 2018, 73 : A121 - A122
  • [29] Impact of benralizumab on asthma exacerbation-related medical healthcare resource utilization and medical costs: results from the ZEPHYR 2 study
    Chung, Yen
    Maselli, Diego J. J.
    Mu, Fan
    Cook, Erin E. E.
    Yang, Danni
    Young, Joshua A. A.
    Betts, Keith A. A.
    Genofre, Eduardo
    Carstens, Donna
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 954 - 962
  • [30] Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study
    Kupczyk, Maciej
    Haque, Shushila
    Sterk, Peter J.
    Nizankowska-Mogilnicka, Ewa
    Papi, Alberto
    Bel, Elisabeth H.
    Chanez, Pascal
    Dahlen, Barbro
    Gaga, Mina
    Gjomarkaj, Mark
    Howarth, Peter H.
    Johnston, Sebastian L.
    Joos, Guy F.
    Kanniess, Frank
    Tzortzaki, Eleni
    James, Anna
    Middelveld, Roelinde J. M.
    Dahlen, Sven-Erik
    THORAX, 2013, 68 (07) : 611 - 618